Citations

Clear

158 citation(s) found for "Hartman, A-R".

Risk of Lower and Upper Gastrointestinal Bleeding, Transfusions, and Hospitalizations With Complex Antithrombotic Therapy in Elderly Patients
Abraham, Neena S. , Hartman, Christine , Richardson, Peter, Castillo, Diana, Street, Richard L. , Naik, Aanand D.

Mayo Clinic

Circulation | September 12, 2013 | Volume: 128 | Issue: 17 | Pages: 1869-1877

10.1161/circulationaha.113.004747 | PMID 24025594 Get It

Background— Complex antithrombotic therapy (CAT) prescribed to elderly patients increases the risk of gastrointestinal bleeding. We quantified upper (UGIE) and lower gastrointestinal (LGIE) events, transfusions, and hospitalizations in a national cohort of elderly veterans prescribed CAT. Methods and Results— Veterans ≥60 years of age prescribed anticoagulant-antiplatelet, aspirin (ASA)-antiplatelet, ASA-anticoagulant, or triple therapy (ie, TRIP, anticoagulant-antiplatelet-ASA) were identified from the national pharmacy database (October 1, 2002 to September 30, 2008). Prescription-fill data were linked to Veteran Affairs and Medicare encounter files, each person-day of follow-up was assessed for CAT exposure, and outcomes were defined by using diagnostic code algorithms derived following chart abstraction. Incidence density ratios (compared with the reference category of no CAT) and survival analysis was conducted. Among 78 133 veterans (98.6% white; mean age, 72.3 [standard deviation 7.7]), 64% were prescribed ASA-antiplatelet and anticoagulant-antiplatelet and 6% were prescribed TRIP. The incidence of UGIE was 20.1/1000 patient-years, and the incidence of LGIE was 70.1/1000 patient-years. ASA-anticoagulant and TRIP were associated with the highest incidence of transfusion and hospitalization. A 40% to 60% increased risk of UGIE was observed with all strategies. LGIE was 30% higher with anticoagulant-antiplatelet, and transfusion increased with ASA-anticoagulant (hazard ratio, 6.1; 95% confidence interval, 5.2–7.1) and TRIP (hazard ratio, 5.0; 95% confidence interval, 4.2–5.8). Increased risk of hospitalization was noted with all strategies. The number needed to harm for UGIE or LGIE ranged from 52 to 65 and 15 to 23, respectively. The number needed to harm for hospitalization was 39 (anticoagulant-antiplatelet), 34 (ASA-anticoagulant), 67 (ASA-antiplatelet), and 45 (TRIP) patients. Conclusions— Among elderly patients, CAT-related LGIE and UGIE are clinically relevant risks resulting in increased hospitalizations and transfusions.
Malignant Melanoma with Delayed Metastatic Growths
Wilbur, Dwight L., HARTMAN, HOWARD R.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 5 | Issue: 2 | Pages: 201-211

10.7326/0003-4819-5-2-201 Get It

The Effect of Cholecystectomy On Gastric Acidity
HARTMAN, HOWARD R., Rivers, Andrew B.

Mayo Clinic

Annals of Internal Medicine | April 11, 2013 | Volume: 1 | Issue: 8 | Pages: 558-562

10.7326/0003-4819-1-8-558 Get It

Screening for Lung Cancer with Low-Dose Spiral Computed Tomography
Swensen, Stephen J., Jett, James R., Sloan, Jeff A. , Midthun, David E. , Hartman, Thomas E. , Sykes, Anne-Marie , Aughenbaugh, Gregory L., Zink, Frank E., Hillman, Shauna L., NOETZEL, GAYLE R., Marks, Randolph S., Clayton, Amy C., Pairolero, Peter C.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 165 | Issue: 4 | Pages: 508-513

10.1164/ajrccm.165.4.2107006 | PMID 11850344 Get It

Abstract Studies suggest that screening with spiral computed tomography can detect lung cancers at a smaller size and earlier stage than chest radiography can. To evaluate low-radiation-dose spiral computed tomography and sputum cytology in screening for lung cancer, we enrolled 1,520 individuals aged 50 yr or older who had smoked 20 pack-years or more in a prospective cohort study. One year after baseline scanning, 2,244 uncalcified lung nodules were identified in 1,000 participants (66%). Twenty-five cases of lung cancer were diagnosed (22 prevalence, 3 incidence). Computed tomography alone detected 23 cases; sputum cytology alone detected 2 cases. Cell types were: squamous cell, 6; adenocarcinoma or bronchioalveolar, 15; large cell, 1; small cell, 3. Twenty-two patients underwent curative surgical resection. Seven benign nodules were resected. The mean size of the non-small cell cancers detected by computed tomography was 17 mm (median, 13 mm). The postsurgical stage was IA, 13; IB, 1; IIA, 5; IIB, 1; IIIA, 2; limited, 3. Twelve (57%) of the 21 non-small cell cancers detected by computed tomography were stage IA at diagnosis. Computed tomography can detect early-stage lung cancers. The rate of benign nodule detection is high.
Polymyositis–Dermatomyositis-associated Interstitial Lung Disease
Douglas, William W., Tazelaar, Henry D. , Hartman, Thomas E. , Hartman, Robert P. , Decker, Paul A. , Schroeder, Darrell R. , Ryu, Jay H. , Tazelaar, Henry D. , Decker, Paul A. , Ryu, Jay H , Schroeder, Darrell

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 164 | Issue: 7 | Pages: 1182-1185

10.1164/ajrccm.164.7.2103110 | PMID 11673206 Get It

Abstract We report findings in 70 patients with both diffuse interstitial lung disease and either polymyositis (PM) or dermatomyositis (DM). Initial presentations were most commonly either musculoskeletal (arthralgias, myalgias, and weakness) or pulmonary (cough, dyspnea, and fever) symptoms alone; in only 15 patients (21.4%) did both occur simultaneously. Pulmonary disease usually took the form of acute to subacute antibiotic-resistant community-acquired pneumonia. Chest radiographs and computed tomography most commonly demonstrated bilateral irregular linear opacities involving the lung bases; occasionally consolidation was present. Jo-1 antibody was present in 19 (38%) of 50 patients tested. Synchronous associated malignancy was present in 4 of 70 patients (5.7%). Surgical lung biopsies disclosed nonspecific interstitial pneumonia (NSIP) in 18 of 22 patients (81.8%), organizing diffuse alveolar damage (DAD) in 2, bronchiolitis obliterans organizing pneumonia (BOOP) in 1, and usual interstitial pneumonia (UIP) in 1. Treatment usually included prednisone in 40–60 mg/d dosages for initial control, followed by lower dose prednisone plus an immunosuppressive agent such as azathioprine or methotrexate for disease suppression. Survival was significantly better than that observed for historical control subjects with idiopathic UIP, and was more consistent with survival previously reported in idiopathic NSIP. There was no difference in survival between Jo-1 positive and Jo-1 negative groups.
Perceptions and Practices of Therapeutic Hypothermia in American Neonatal Intensive Care Units
Harris, Malinda N. , Ellsworth, Marc A., Haas, Lindsey R., Hartman, Tyler, Lang, Tara R., Colby, Christopher E. , Carey, William A.

Mayo Clinic

American Journal of Perinatology | March 2, 2013 | Volume: 31 | Issue: 01 | Pages: 015-020

10.1055/s-0033-1334454 | PMID 23456901 Get It

Lung Cancer Screening Experience: A Retrospective Review of PET in 22 Non-Small Cell Lung Carcinomas Detected on Screening Chest CT in a High-Risk Population
Lindell, Rebecca M. , Hartman, Thomas E. , Swensen, Stephen J., Jett, James R., Midthun, David E. , Nathan, Mark A., Lowe, Val J.

Mayo Clinic

American Journal of Roentgenology | February 28, 2013 | Volume: 185 | Issue: 1 | Pages: 126-131

10.2214/ajr.185.1.01850126 | PMID 15972412 Get It

Effect of Granulocyte-Stimulating Factors on Marrow of Adult Patients with Musculoskeletal Malignancies: Incidence and MRI Findings
Hartman, Robert P. , Okuno, Scott H. , Sim, Franklin H. , Sundaram, Murali

Mayo Clinic

American Journal of Roentgenology | February 28, 2013 | Volume: 183 | Issue: 3 | Pages: 645-653

10.2214/ajr.183.3.1830645 | PMID 15333351 Get It

Oxygen dose responsiveness of human fetal airway smooth muscle cells
Hartman, William R. , Smelter, Dan F. , Sathish, Venkatachalem , Karass, Michael , Kim, Sunchin, Aravamudan, Bharathi, Amrani, Yassine , Pandya, Hitesh , Martin, Richard J. , Prakash, Y. S. , Thompson, Michael A. , Pabelick, Christina M. , Prakash, Y S , Sathish, Venkatachalem

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | August 24, 2012 | Volume: 303 | Issue: 8 | Pages: L711-L719

10.1152/ajplung.00037.2012 | PMID 22923637 Get It

Maintenance of blood oxygen saturation dictates supplemental oxygen administration to premature infants, but hyperoxia predisposes survivors to respiratory diseases such as asthma. Although much research has focused on oxygen effects on alveoli in the setting of bronchopulmonary dysplasia, the mechanisms by which oxygen affects airway structure or function relevant to asthma are still under investigation. We used isolated human fetal airway smooth muscle (fASM) cells from 18–20 postconceptual age lungs (canalicular stage) to examine oxygen effects on intracellular Ca 2+ ([Ca 2+ ] i ) and cellular proliferation. fASM cells expressed substantial smooth muscle actin and myosin and several Ca 2+ regulatory proteins but not fibroblast or epithelial markers, profiles qualitatively comparable to adult human ASM. Fluorescence Ca 2+ imaging showed robust [Ca 2+ ] i responses to 1 μM acetylcholine (ACh) and 10 μM histamine (albeit smaller and slower than adult ASM), partly sensitive to zero extracellular Ca 2+ . Compared with adult, fASM showed greater baseline proliferation. Based on this validation, we assessed fASM responses to 10% hypoxia through 90% hyperoxia and found enhanced proliferation at <60% oxygen but increased apoptosis at >60%, effects accompanied by appropriate changes in proliferative vs. apoptotic markers and enhanced mitochondrial fission at >60% oxygen. [Ca 2+ ] i responses to ACh were enhanced for <60% but blunted at >60% oxygen. These results suggest that hyperoxia has dose-dependent effects on structure and function of developing ASM, which could have consequences for airway diseases of childhood. Thus detrimental effects on ASM should be an additional consideration in assessing risks of supplemental oxygen in prematurity.
An Underreported Consequence of Obesity in Pregnancy: Patient-Prosthesis Mismatch
Hartman, William R. , Rehfeldt, Kent H., Arendt, Katherine W.

Mayo Clinic

Case Reports in Obstetrics and Gynecology | July 8, 2012 | Volume: 2012 | Issue: No issue available | Pages: 1-4

10.1155/2012/918352 | PMID 22830065 Get It

As the rate of obesity increases in childbearing-aged women, so too will the complications of obesity in pregnancy. An uncommon and likely underreported complication occurs in obese women who have received prepregnancy cardiac valve replacement with a prosthesis that is inadequately sized for body habitus, a condition referred to as patient-prosthesis mismatch (PPM). The physiologic changes of pregnancy as well as the increased weight gain combine to exacerbate PPM. We report a case of PPM that necessitated prosthesis replacement at 16-week gestation. As the incidence of this clinical scenario increases, it is important to understand the implications of prosthesis sizing, as well as the repercussions of having cardiopulmonary surgery to correct the undersized valve prosthesis while pregnant.